National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 2,116 cases where Vaccine is COVID19 and Symptom is Guillain-Barre syndrome

Government Disclaimer on use of this data



Case Details

This is page 15 out of 212

Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next


VAERS ID: 1213445 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Male  
Location: Michigan  
Vaccinated:2021-02-10
Onset:2021-03-12
   Days after vaccination:30
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Protein total abnormal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Metoprolol, atorvastatin, imdur, synthroid, lisinopril. protonix, remeron
Current Illness: alcohol intoxication
Preexisting Conditions: CAD s/p CABG, gastric ulcer, HTN, HLD. hypothyrodism, renal calculi, hx of alcoholism
Allergies: penicillin
Diagnostic Lab Data: LP Shows elevated protein,
CDC Split Type:

Write-up: presumed Acute inflammatory demyelinating polyneuropathy (AIDP)


VAERS ID: 1214117 (history)  
Form: Version 2.0  
Age: 44.0  
Sex: Male  
Location: Ohio  
Vaccinated:2021-04-12
Onset:2021-04-14
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 205A21A / UNK RA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Laboratory test, Pain in extremity
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: Yellow Fever Vaccine/2014
Other Medications: Vitamin D, K, Vitamin B complex Multivitamin Fish Oil
Current Illness: None
Preexisting Conditions: None
Allergies: Yellow Fever Vaccine
Diagnostic Lab Data: He received IV Toradol to help out with his extremity pain. Labs were checked to rule out electrolyte disturbance, thrombocytopenia. The patient''s neurologic examination does not demonstrate classic signs of Guillain-Barre, there is no evidence of muscle weakness or paralysis and his deep tendon reflexes are normal. Acute pain has been described in acute Guillain-Barre, and so I gave the patient return precautions regarding progressive symptoms. At this point, there are not enough objective criteria to diagnose him with GBS, symptoms do not suggest the need for hospitalization for observation. Even so, it is clear the severe extremity pain is a result of the vaccine.
CDC Split Type:

Write-up: Patient developed mild case of Guillain Barre Syndrome 34 hours after injection of the Johnson and Johnson vaccine. Patient has severe extremity pains. The patient has a personal history of being diagnosed with Guillain-Barre after a yellow fever vaccination.


VAERS ID: 1214343 (history)  
Form: Version 2.0  
Age: 63.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-03-22
Onset:2021-03-31
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Immunoglobulin therapy
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 13 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Losartan, hydralazine, spironolactone, sodium chloride, levoxyl, aciphex, Prozac, fibercon, Claritin, Flonase.
Current Illness: None
Preexisting Conditions: Hypertension, hypothyroidism, gastric erosion,
Allergies: Prilosec, protonix
Diagnostic Lab Data:
CDC Split Type:

Write-up: Guillen Barre Syndrome, received IVIG. Transferred to rehab after 13 days in hospital.


VAERS ID: 1214664 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Female  
Location: Kentucky  
Vaccinated:2021-04-08
Onset:2021-04-08
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -

Administered by: School       Purchased by: ?
Symptoms: Asthenia, Breast cancer, Chills, Diarrhoea, Fatigue, Guillain-Barre syndrome, Hypoaesthesia, Lymphadenopathy, Septic shock
SMQs:, Peripheral neuropathy (narrow), Toxic-septic shock conditions (narrow), Pseudomembranous colitis (broad), Guillain-Barre syndrome (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Breast malignant tumours (narrow), Noninfectious diarrhoea (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Non-haematological malignant tumours (narrow), Sepsis (narrow), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: thyroid, thyroxin
Current Illness: no
Preexisting Conditions: no
Allergies: latex
Diagnostic Lab Data:
CDC Split Type:

Write-up: complete numbness of entire right side of my body; same side where I received the vaccine. after 4-6 hours after shot. lasted almost two days. scalp, cheek, eye socket numb and worried. cortisone and zovirax to prevent bell?s palsey. reported to VAERS and no one seems to care. no swelling of lymph nodes yet after almost one week. diarrhea severe. cortisone helped but affects immune response and antibodies so stopped steroid. will not get second. Guillain-Barr� syndrome and septic shock, cytokine storm, autoimmunity, run in the family. just want people to be aware and wish they?d tell people. I?m in the medical field and not an anti vaxer. chills, fatigue weakness but I expected that. statistics don?t matter unless it affects you and your family members. I?m doing lymphatic drainage for lymphedema also, like for breast cancer patients.


VAERS ID: 1214758 (history)  
Form: Version 2.0  
Age: 38.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-03-05
Onset:2021-03-10
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: NKDA
Diagnostic Lab Data:
CDC Split Type:

Write-up: Per neurologist "agree with dx of Guillain-Barre Syndrome secondary to COVID vaccine"


VAERS ID: 1214887 (history)  
Form: Version 2.0  
Age: 68.0  
Sex: Female  
Location: North Carolina  
Vaccinated:2021-03-26
Onset:2021-03-28
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER2613 / 2 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: eliquis, diltiazem, cymbalta, levsin, synthroid, inderal, trazodone, vitamin d3
Current Illness:
Preexisting Conditions:
Allergies: pneumonia vaccine, mri contrast
Diagnostic Lab Data:
CDC Split Type:

Write-up: gullian barres


VAERS ID: 1220858 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Texas  
Vaccinated:2021-01-09
Onset:2021-01-09
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Bell's palsy, Guillain-Barre syndrome, Headache, Lethargy, Muscular weakness, Pain in extremity, Paraesthesia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Lumbar puncture
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: he had a lot more weakness in arms and legs; his arm started tingling/his feel also started tingling; strong headache; bilateral facial bell''s palsy; Guillen Barre Syndrome; a bit sluggish; arm ached; headache; sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (his arm started tingling/his feel also started tingling), MUSCULAR WEAKNESS (he had a lot more weakness in arms and legs), GUILLAIN-BARRE SYNDROME (Guillen Barre Syndrome), FACIAL PARALYSIS (bilateral facial bell''s palsy) and HEADACHE (strong headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient''s past medical history included Lumbar puncture. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 09-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 06-Feb-2021, the patient experienced LETHARGY (a bit sluggish), PAIN IN EXTREMITY (arm ached) and HEADACHE (headache). On 12-Feb-2021, the patient experienced HEADACHE (strong headache) (seriousness criterion hospitalization). On 13-Feb-2021, the patient experienced PARAESTHESIA (his arm started tingling/his feel also started tingling) (seriousness criterion hospitalization). On 15-Feb-2021, the patient experienced MUSCULAR WEAKNESS (he had a lot more weakness in arms and legs) (seriousness criterion hospitalization). On 16-Feb-2021, the patient experienced GUILLAIN-BARRE SYNDROME (Guillen Barre Syndrome) (seriousness criterion hospitalization). On an unknown date, the patient experienced FACIAL PARALYSIS (bilateral facial bell''s palsy) (seriousness criterion hospitalization). The patient was hospitalized from 12-Feb-2021 to 23-Feb-2021 due to FACIAL PARALYSIS and GUILLAIN-BARRE SYNDROME. At the time of the report, LETHARGY (a bit sluggish), PAIN IN EXTREMITY (arm ached), GUILLAIN-BARRE SYNDROME (Guillen Barre Syndrome), FACIAL PARALYSIS (bilateral facial bell''s palsy), PAIN IN EXTREMITY (sore arm) and HEADACHE (headache) had resolved and PARAESTHESIA (his arm started tingling/his feel also started tingling), MUSCULAR WEAKNESS (he had a lot more weakness in arms and legs) and HEADACHE (strong headache) had not resolved. Not Provided Treatment include IVIG treatment and Steroids. Company Comment: Very limited information regarding these events has been provided at this time. Further information has been requested. This case was linked to MOD-2021-056405 (Patient Link). Reporter did not allow further contact; Sender''s Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.


VAERS ID: 1221284 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: California  
Vaccinated:2021-03-03
Onset:2021-03-17
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Blood test, Computerised tomogram, Electrocardiogram, Guillain-Barre syndrome, Pain in extremity, Ultrasound scan, X-ray
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Lisinopril,Alpurinal
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: 4/2/2021 Blood test,cat scan,X-rays,ultra sound,EKG
CDC Split Type:

Write-up: I am diagnosed with Gillian Barr Syndrome after 2 weeks of extreme pain in my hand,legs and feet. This is a rare Auto Immune Disease that was brought on after the second dose of the Pfizer vaccine.


VAERS ID: 1223655 (history)  
Form: Version 2.0  
Age: 63.0  
Sex: Male  
Location: Utah  
Vaccinated:2021-03-10
Onset:2021-03-13
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805020 / UNK LA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Fatigue, Guillain-Barre syndrome, Headache, Illness, Lumbar puncture abnormal, Magnetic resonance imaging, Muscular weakness, Pain in extremity, Paraesthesia, Ultrasound scan
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Hearing impairment (broad), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: lisinopril pantoprazole
Current Illness: none
Preexisting Conditions: none
Allergies: penicillins, quinoloness
Diagnostic Lab Data: Several blood tests, mri''s, ct scan, spinal tap and ultra sound on neck. Put on anti viral and prednisone. Scheduled for infusion therapy.
CDC Split Type:

Write-up: tingling in hands and feet, headache, tired, bilateral bells palsy. Pain in arms and legs and weakness with extreme fatigue. Went to the ER, twice and was admitted. . Diagnosed with guillain-barr� syndrome. Still sick.


VAERS ID: 1224836 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Florida  
Vaccinated:0000-00-00
Onset:2021-04-06
Submitted: 0000-00-00
Entered: 2021-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Confusional state, Death, Dehydration, Guillain-Barre syndrome, Laboratory test, Lethargy, Lumbar puncture, Urinary incontinence
SMQs:, Peripheral neuropathy (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hypoglycaemia (broad), Dehydration (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-06
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: tests; Result Unstructured Data: Test Result:diagnosed with Guillain-Barre Syndrome; Test Name: lumbar puncture; Result Unstructured Data: Test Result:diagnosed with Guillain-Barre Syndrome
CDC Split Type: USPFIZER INC2021381625

Write-up: Guillain-Barre Syndrome; urinary incontinence; confusion; lethargy; dehydration; expired; This is a spontaneous report from a contactable physician. A 76-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiry were not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient received first dose of bnt162b2 on an unspecified date for Covid-19 immunization. The patient''s medical history and concomitant medications were not reported. The physician reported that the patient received his second Pfizer vaccine dose and 2 weeks after receiving the vaccine he presented to her office with urinary incontinence, confusion and lethargy. He was admitted to the hospital and within a few days later, day 5, he was diagnosed with Guillain-Barre Syndrome. Following tests and a lumbar puncture. He was hospitalized x2 weeks, received IVIG x 5days. He was then transferred to a Nursing Home. He was readmitted to the hospital with dehydration and expired 2 days later (last night). The physician asked, "have you seen this type of thing before, with GBS?" The physician considered the case as non-serious. The outcome of the events was unknown except for expired. The patient died on 06Apr2021 as he expired. There was no autopsy done. Information on the lot/batch number has been requested.; Sender''s Comments: Limited information precludes a medically meaningful assessment of the case. Based on the current available information, a possible contributory role of the suspect product to the development of events cannot be totally excluded. Additional information including relevant medical history, detailed clinical course, and specified concomitant medications is required to better assess the case. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: expired


Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=15&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166